ImmuCell Corporation
ICCC
$6.52
$0.345.50%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.45M | 514.60K | -701.70K | -1.53M | -437.90K |
| Total Depreciation and Amortization | 676.00K | 673.80K | 675.10K | 671.00K | 667.30K |
| Total Amortization of Deferred Charges | 10.80K | 10.80K | 10.80K | 10.80K | 10.20K |
| Total Other Non-Cash Items | 19.10K | 32.30K | 40.10K | 75.10K | 43.70K |
| Change in Net Operating Assets | -579.00K | -1.23M | -663.70K | 1.36M | 135.20K |
| Cash from Operations | 1.57M | -3.10K | -639.30K | 581.80K | 418.50K |
| Capital Expenditure | -329.10K | -196.20K | -88.40K | -110.70K | -70.40K |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 0.00 | 4.50K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -329.10K | -196.20K | -88.40K | -106.20K | -70.40K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -380.10K | -374.20K | -368.30K | -364.40K | -361.50K |
| Issuance of Common Stock | 19.40K | 814.90K | 3.58M | 252.70K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -43.00K | -291.80K | 0.00 | 0.00 | -5.00K |
| Cash from Financing | -403.60K | 148.90K | 3.21M | -111.60K | -366.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 841.10K | -50.40K | 2.48M | 363.90K | -18.40K |